Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ZYDUS LIFESCIENCES DIVIS LABORATORIES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 31.5 19.4 162.4% View Chart
P/BV x 8.3 2.3 362.2% View Chart
Dividend Yield % 0.8 0.6 125.9%  

Financials

 DIVIS LABORATORIES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
ZYDUS LIFESCIENCES
Mar-22
DIVIS LABORATORIES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs5,425674 805.3%   
Low Rs3,562331 1,076.1%   
Sales per share (Unadj.) Rs337.5149.1 226.3%  
Earnings per share (Unadj.) Rs111.522.7 490.7%  
Cash flow per share (Unadj.) Rs123.329.7 415.1%  
Dividends per share (Unadj.) Rs30.002.50 1,200.0%  
Avg Dividend yield %0.70.5 134.2%  
Book value per share (Unadj.) Rs441.8166.1 266.1%  
Shares outstanding (eoy) m265.471,023.74 25.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.4 395.2%   
Avg P/E ratio x40.322.1 182.3%  
P/CF ratio (eoy) x36.516.9 215.5%  
Price / Book Value ratio x10.23.0 336.2%  
Dividend payout %26.911.0 244.5%   
Avg Mkt Cap Rs m1,192,890514,277 232.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46221,777 43.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598152,652 58.7%  
Other income Rs m1,1592,354 49.2%   
Total revenues Rs m90,757155,006 58.6%   
Gross profit Rs m38,81134,427 112.7%  
Depreciation Rs m3,1157,130 43.7%   
Interest Rs m201,270 1.6%   
Profit before tax Rs m36,83528,381 129.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2315,117 141.3%   
Profit after tax Rs m29,60523,264 127.3%  
Gross profit margin %43.322.6 192.1%  
Effective tax rate %19.618.0 108.9%   
Net profit margin %33.015.2 216.8%  
BALANCE SHEET DATA
Current assets Rs m96,104122,614 78.4%   
Current liabilities Rs m24,54478,394 31.3%   
Net working cap to sales %79.929.0 275.7%  
Current ratio x3.91.6 250.3%  
Inventory Days Days993 9.4%  
Debtors Days Days98780 1,236.3%  
Net fixed assets Rs m50,087144,382 34.7%   
Share capital Rs m5311,024 51.8%   
"Free" reserves Rs m116,751168,972 69.1%   
Net worth Rs m117,282169,996 69.0%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m146,191266,996 54.8%  
Interest coverage x1,842.823.3 7,892.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.6 107.2%   
Return on assets %20.39.2 220.5%  
Return on equity %25.213.7 184.5%  
Return on capital %31.417.1 184.0%  
Exports to sales %00-   
Imports to sales %19.714.3 137.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,67621,869 80.8%   
Fx inflow Rs m78,44563,065 124.4%   
Fx outflow Rs m17,95321,869 82.1%   
Net fx Rs m60,49241,196 146.8%   
CASH FLOW
From Operations Rs m19,11821,041 90.9%  
From Investments Rs m-21,94911,544 -190.1%  
From Financial Activity Rs m-5,324-8,683 61.3%  
Net Cashflow Rs m-8,15623,729 -34.4%  

Share Holding

Indian Promoters % 51.9 74.9 69.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.5 14.9 245.4%  
FIIs % 16.5 2.9 577.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 25.1 191.3%  
Shareholders   346,905 455,624 76.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Divis Laboratories vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Cadila Healthcare Share Price Performance

Period Divis Laboratories Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.25% 0.82% 0.67%
1-Month 1.64% 2.29% 1.42%
1-Year -23.22% -29.94% -10.55%
3-Year CAGR 30.32% 18.32% 23.16%
5-Year CAGR 33.89% -4.01% 11.48%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Cadila Healthcare the stake stands at 74.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.